- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/51 - Bone morphogenic factorOsteogeninOsteogenic factorBone-inducing factor
Patent holdings for IPC class C07K 14/51
Total number of patents in this class: 401
10-year publication summary
|
36
|
35
|
32
|
29
|
28
|
19
|
23
|
24
|
11
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Enzo Biochem, Inc. | 107 |
14 |
| The Regents of the University of California | 20720 |
13 |
| Wyeth LLC | 608 |
12 |
| Theradaptive, Inc. | 37 |
10 |
| Amgen Inc. | 4425 |
9 |
| Acceleron Pharma Inc. | 341 |
9 |
| Histide AG | 25 |
8 |
| Warsaw Orthopedic, Inc. | 2784 |
7 |
| President and Fellows of Harvard College | 6091 |
7 |
| Cellivery Therapeutics, Inc. | 42 |
7 |
| LifeNet Health | 283 |
7 |
| Seoul National University R&db Foundation | 4154 |
7 |
| Ubiprotein, Corp. | 12 |
7 |
| Brookhaven Science Associates, LLC | 202 |
6 |
| Ferring B.V. | 716 |
6 |
| The Brigham and Women's Hospital, Inc. | 2282 |
5 |
| The Cleveland Clinic Foundation | 1575 |
5 |
| The United States of America as represented by the Department of Veterans Affairs | 298 |
5 |
| Alivegen Inc | 7 |
5 |
| Agency for Science, Technology and Research | 3729 |
4 |
| Other owners | 248 |